phase readout

NCT05797233: Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

ACTIVE_NOT_RECRUITINGupdated 36m ago

community read0 votes

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell

view source ↗

Data sources

ctgov

last refreshed 36m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?